Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Revvity Omics, |
RCV001781071 | SCV002024551 | likely pathogenic | not provided | 2021-03-30 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003626687 | SCV004519495 | pathogenic | Congenital prothrombin deficiency | 2023-03-01 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln387*) in the F2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in F2 are known to be pathogenic (PMID: 23852823). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with F2-related conditions. ClinVar contains an entry for this variant (Variation ID: 1324366). For these reasons, this variant has been classified as Pathogenic. |